Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

Treatment Resistent Cancers

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Early human contact and housing for pigs - part 2: resilience to routine husbandry practices.

Animal : an international journal of animal bioscience·2024

Same author

Early human contact and housing for pigs - part 3: ability to cope with the environment.

Animal : an international journal of animal bioscience·2024

Same author

Early human contact and housing for pigs - part 1: responses to humans, novelty and isolation.

Animal : an international journal of animal bioscience·2024

Same author

Group lactation from 7 or 14 days of age reduces piglet aggression at weaning compared to farrowing crate housing.

Animal : an international journal of animal bioscience·2019

Same author

Higher light intensity and mat temperature attract piglets to creep areas in farrowing pens.

Animal : an international journal of animal bioscience·2019

Same author

Forming groups of aggressive sows based on a predictive test of aggression does not affect overall sow aggression or welfare.

Behavioural processes·2018

Search research articles

Related Experiment Video

Updated: May 22, 2026

Strategy for Biobanking of Ovarian Cancer Organoids: Addressing the Interpatient Heterogeneity across Histological Subtypes and Disease Stages

Strategy for Biobanking of Ovarian Cancer Organoids: Addressing the Interpatient Heterogeneity across Histological Subtypes and Disease Stages

Published on: February 23, 2024

Palliative oncology: identity, progress, and the path ahead.

A S Epstein¹, R S Morrison

¹The Lilian and Benjamin Hertzberg Palliative Care Institute of the Brookdale Department of Geriatrics and Palliative Medicine, Mount Sinai School of Medicine, One Gustave L. Levy Place, New York, NY 10029, USA.

Annals of Oncology : Official Journal of the European Society for Medical Oncology

|May 26, 2012

Summary

Palliative care enhances support for patients with serious illnesses, especially in oncology. This evolving field focuses on improving symptom management and communication between palliative and oncology specialists for better patient outcomes.

Related Experiment Videos

Last Updated: May 22, 2026

Strategy for Biobanking of Ovarian Cancer Organoids: Addressing the Interpatient Heterogeneity across Histological Subtypes and Disease Stages

Strategy for Biobanking of Ovarian Cancer Organoids: Addressing the Interpatient Heterogeneity across Histological Subtypes and Disease Stages

Published on: February 23, 2024

Area of Science:

Medicine
Oncology
Palliative Care

Background:

Palliative care is a growing medical subspecialty addressing holistic patient needs.
It offers crucial support alongside standard medical treatment for serious illnesses.
Advances in cancer detection and treatment necessitate an evolving role for palliative care in oncology.

Purpose of the Study:

To highlight emerging paradigms in palliative care.
To delineate key areas for education, research, and policy in palliative oncology.
To emphasize the importance of the palliative care and oncology specialist interface.

Main Methods:

Review of emerging trends in palliative oncology.
Identification of key areas for future development in the field.
Focus on the collaborative relationship between palliative care and oncology.

Main Results:

Palliative care plays a vital role in the oncology population due to medical advances.
The interface between palliative care and oncology specialists is critical for comprehensive patient care.
There is a need for improved multi-faceted symptom management and patient-physician communication.

Conclusions:

The collaboration between palliative care and oncology specialists is essential.
Future directions include advancements in education, research, and policy within palliative oncology.
Enhanced integration leads to improved patient care and outcomes.